## GL: Globe Life Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -3.2% below STRENGTH zone (4.0-10.0%); PEG 1.68 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($125.80)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 5)

**1. Globe Life Inc. stock underperforms Tuesday when compared to competitors**
- Source: MarketWatch | 20251202T172100 | Bearish | Relevance: 100%
- Globe Life Inc. (GL) shares fell by 1.04% to $131.15 on Tuesday, extending its losing streak to a fourth consecutive day. This underperformance occurred despite an overall positive trading session for the broader market, with both the S&P 500 Index (SPX) and the Dow Jones Industrial Average (DJIA) closing higher.

**2. Bronstein, Gewirtz & Grossman, LLC Is Investigating Globe Life Inc. (GL) And Encourages Investors to Connect**
- Source: KLAS 8 News Now | 20251202T160000 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. (NYSE: GL) whose securities were acquired prior to May 8, 2019, and are still held. The investigation concerns whether Globe Life and its officers/directors engaged in corporate wrongdoing. Investors are encouraged to connect with the firm to assist in the investigation without any cost.

**3. Bronstein, Gewirtz & Grossman, LLC Is Investigating Globe Life Inc. (GL) And Encourages Investors to Connect**
- Source: mypanhandle.com | 20251202T110000 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has announced an investigation into potential claims against Globe Life Inc. (NYSE:GL) and its officers/directors for corporate wrongdoing. The firm is encouraging investors who purchased Globe Life securities before May 8, 2019, and still hold them, to connect and assist with the investigation. The representation of investors in class actions is on a contingency fee basis, meaning fees are only sought if successful.

**4. Norges Bank Invests $157.72 Million in Globe Life Inc. $GL**
- Source: MarketBeat | 20251203T190824 | Bullish | Relevance: 100%
- Norges Bank has initiated a new position in Globe Life Inc. (NYSE:GL), purchasing 1,268,980 shares valued at $157.72 million, which represents 1.57% of the company. Other institutional investors like Nuveen, Leith Wheeler, and Swedbank also increased their stakes, leading to an overall institutional and hedge-fund ownership of 81.61%. Analysts have a "Moderate Buy" rating with a consensus price target of $155.56, following strong Q3 EPS and positive FY2026 guidance, alongside the announcement of a quarterly dividend.

**5. Arrowstreet Capital Limited Partnership Reduces Position in Globe Life Inc. $GL**
- Source: MarketBeat | 20251203T120819 | Somewhat-Bullish | Relevance: 100%
- Arrowstreet Capital Limited Partnership reduced its stake in Globe Life Inc. by 5.3% in the second quarter, selling 62,547 shares but still maintaining a significant holding worth $139.5 million. Meanwhile, other institutional investors like Norges Bank increased their positions, contributing to institutional ownership of 81.61% of Globe Life's shares. The company recently reported strong Q3 earnings, beating analyst expectations, and declared a quarterly dividend of $0.27 per share.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | Morgan Stanley | $177 | $179 | -1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($3.74M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 12.6% (-2.7%)
- Blackrock Inc.: 7.2% (-2.1%)
- Invesco Ltd.: 4.8% (-1.9%)
- State Street Corpora: 4.1% (-3.5%)
- Wellington Managemen: 3.5% (-29.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.68 elevated, pricing in significant growth expectations. Forward P/E 8.7x stretched relative to 3% growth. Quality metrics strong (ROE 22%, margin 19%). Balance sheet: strong liquidity (2.8x). Analyst sentiment negative (1 target cuts vs 0 raises). Insider buying signal ($3.7M), management confidence. Institutional flow bullish (2 buying vs 8 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.5B |
| Beta | 0.48 |
| 52W Range | $107.25 - $147.83 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.68 |
| Forward P/E | 8.7 |
| Current P/E | 9.0 |
| YoY Growth | 2.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.1% to -3.2% (-4.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.2pp (needs >4.0% for momentum thesis). Underperforming sector by 3.2pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.01x) but short-term weakness (below SMA20). RSI neutral at 41. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.17% (CS: 21) | Weak |
| RSI_14 | 41.4 | Neutral |
| MACD Histogram | 0.08 | Bullish |
| vs SMA20 | 0.987x | Below |
| vs SMA50 | 0.969x | Below |
| vs SMA200 | 1.010x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $130.82
- **Stop Loss:** $125.80 (3.8% risk)
- **Target:** $135.84 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 189
- **Position Value:** $24,724.98
- **Portfolio %:** 24.72%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-04 (Est: $3.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.54 | $4.81 | +5.9% |
| 2025Q2 | $3.25 | $3.27 | +0.8% |
| 2025Q1 | $3.24 | $3.07 | -5.2% |
| 2024Q4 | $3.12 | $3.14 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*